Dr. Mamta K. Jain

Internal Medicine
3115 College Park Dr, Suite 112, 
The Woodlands, TX 
Accepting New Patients
28 Years of Experience
3115 College Park Dr, Suite 112, 
The Woodlands, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mamta Jain is a primary care provider, practicing in Internal Medicine in The Woodlands, Texas. Dr. Jain has been practicing medicine for over 28 years and is rated as an Experienced provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, Hepatitis B, and Endoscopy. Dr. Jain is currently accepting new patients.

Her clinical research consists of co-authoring 138 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in TX
Hospital Affiliations
Chi St Lukes Lakeside Hospital
Memorial Hermann Hospital System
Houston Methodist The Woodlands Hospital
St Luke's The Woodlands Hospital
Languages Spoken
English
Hindi
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

3115 College Park Dr, Suite 112, The Woodlands, TX 77384

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Terminated
Publish Date: November 13, 2025
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
HBV-HIV Coinfection Research Network
HBV-HIV Coinfection Research Network
Enrollment Status: Completed
Publish Date: May 16, 2023
Human Immunodeficiency Virus Acquired Lipodystrophy (HAL) Classification, Measurement, & Fat Response to a Thiazolidinedione (TZD) Challenge in Differing Adult Phenotypic Presentations
Human Immunodeficiency Virus Acquired Lipodystrophy (HAL) Classification, Measurement, & Fat Response to a Thiazolidinedione (TZD) Challenge in Differing Adult Phenotypic Presentations
Enrollment Status: Completed
Publish Date: October 08, 2019
Intervention Type: Other, Drug
Study Phase: Not Applicable
A Prospective, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate Whether EGRIFTA® (Tesamorelin for Injection), 2 mg Once Daily SC, Increases the Risk of Development or Progression of Diabetic Retinopathy When Administered to HIV-infected Subjects With Abdominal Lipohypertrophy and Concomitant Diabetes
A Prospective, Randomized, Placebo-controlled, Double-blind Clinical Trial to Evaluate Whether EGRIFTA® (Tesamorelin for Injection), 2 mg Once Daily SC, Increases the Risk of Development or Progression of Diabetic Retinopathy When Administered to HIV-infected Subjects With Abdominal Lipohypertrophy and Concomitant Diabetes
Enrollment Status: Terminated
Publish Date: September 11, 2018
Intervention Type: Drug
Study Phase: Phase 4
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®
Enrollment Status: Terminated
Publish Date: September 11, 2018
Intervention Type: Drug
View 4 Less Clinical Trials

138 Total Publications

The Potential Impact of Ending the Ryan White HIV/AIDS Program on HIV Incidence: A Simulation Study in 31 U.S. Cities.
The Potential Impact of Ending the Ryan White HIV/AIDS Program on HIV Incidence: A Simulation Study in 31 U.S. Cities.
Journal: Annals of internal medicine
Published: September 08, 2025
Similar Doctors
Advanced in CACH Syndrome
Dr. Firoozeh R. Kar
Internal Medicine
Advanced in CACH Syndrome
Dr. Firoozeh R. Kar
Internal Medicine

Xpertmd

500 W Medical Ctr Blvd, 
Webster, TX 
 (50.3 miles away)
281-332-3001
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients

Firoozeh Kar is a primary care provider, practicing in Internal Medicine in Webster, Texas. Dr. Kar is rated as an Advanced provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are Cellulitis, Muscle Atrophy, End-Stage Renal Disease (ESRD), and Dementia. Dr. Kar is currently accepting new patients.

Experienced in CACH Syndrome
Dr. Tiffany C. Fleet
Internal Medicine
Experienced in CACH Syndrome
Dr. Tiffany C. Fleet
Internal Medicine
8055 Cambridge St Apt 19, 
Houston, TX 
 (36.5 miles away)
443-604-6343
Languages Spoken:
English
See accepted insurances

Tiffany Fleet is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Fleet is rated as an Experienced provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are CACH Syndrome, Non-Alcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis (NASH).

Experienced in CACH Syndrome
Dr. Maria T. Cruz-Carreras
Internal Medicine
Experienced in CACH Syndrome
Dr. Maria T. Cruz-Carreras
Internal Medicine

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
 (34.7 miles away)
713-592-5433
Languages Spoken:
English
See accepted insurances

Maria Cruz-Carreras is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Cruz-Carreras is rated as an Advanced provider by MediFind in the treatment of CACH Syndrome. Her top areas of expertise are Anaplastic Thyroid Cancer, Multiple Myeloma, Idiopathic Neutropenia, and Low Blood Pressure.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jain's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 83 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile